Antibacterial Secondary Metabolites from Marine-Derived Fungus Aspergillus sp. IMCASMF180035

doi:10.3390/antibiotics10040377

IOCAS-IR > 实验海洋生物学重点实验室

	Antibacterial Secondary Metabolites from Marine-Derived Fungus Aspergillus sp. IMCASMF180035
	Song, Fuhang 1; Lin, Rui 2; Yang, Na 3,4; Jia, Jia 5; Wei, Shangzhu 2; Han, Jiahui 2; Li, Jiangpeng 2; Bi, Hongkai ; Xu, Xiuli 2
	2021-04-01
发表期刊	ANTIBIOTICS-BASEL
ISSN	2079-6382
卷号	10 期号:4 页码:9
通讯作者	Song, Fuhang([email protected]) ; Xu, Xiuli([email protected])
摘要	Four new secondary metabolites, including one spiro[anthracenone-xanthene] derivative aspergiloxathene A (1), one penicillide analogue, Delta(2 ')-1 '-dehydropenicillide (2), and two new phthalide derivatives, 5-methyl-3-methoxyepicoccone (3) and 7-carboxy-4-hydroxy-6-methoxy-5-methylphthalide (4), together with four known compounds, yicathin C (5), dehydropenicillide (6), 3-methoxyepicoccone (7), 4-hydroxy-6-methoxy-5-methylphthalide (8), were identified from the marine-derived fungus Aspergillus sp. IMCASMF180035. Their structures were determined by spectroscopic data, including high-resolution electrospray ionization mass spectrometry (HRESIMS), 1D and 2D nuclear magnetic resonance (NMR) techniques. Compound 1 was identified as the first jointed molecule by xanthene and anthracenone moieties possessing an unprecedented carbon skeleton with spiro-ring system. All compounds were evaluated activities against Staphylococcus aureus, methicillin resistant S. aureus (MRSA), Escherichia coli, Escherichia faecium, Pseudomonas aeruginosa, and Helicobacter pylori. Compound 1 showed significant inhibitory effects against S. aureus and MRSA, with minimum inhibitory concentration (MIC) values of 5.60 and 22.40 mu M. Compounds 2 and 6 exhibited potent antibacterial activities against H. pylori, with MIC values of 21.73 and 21.61 mu M, respectively.
关键词	marine-derived fungus Aspergillus sp natural products anti-Staphylococcus aureus anti-Helicobacter pylori
DOI	10.3390/antibiotics10040377
收录类别	SCI
语种	英语
资助项目	National Key R&D Program of China[2018YFC0311000]; Key Lab of Marine Bioactive Substance and Modern Analytical Technique, SOA[MBSMAT-2019-06]; National Natural Science Foundation of China[81973204]; Research Foundation for Advanced Talents of Beijing Technology and Business University[19008020158]
WOS研究方向	Infectious Diseases ; Pharmacology & Pharmacy
WOS类目	Infectious Diseases ; Pharmacology & Pharmacy
WOS记录号	WOS:000642678600001
出版者	MDPI
引用统计	被引频次：14[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.qdio.ac.cn/handle/337002/170601
专题	实验海洋生物学重点实验室
通讯作者	Song, Fuhang; Xu, Xiuli
作者单位	1.Beijing Technol & Business Univ, Sch Light Ind, Beijing 100048, Peoples R China 2.China Univ Geosci, Sch Ocean Sci, Beijing 100083, Peoples R China 3.Chinese Acad Sci, Inst Oceanol, CAS Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China 4.Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China 5.Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol, Nanjing 211166, Peoples R China
推荐引用方式 GB/T 7714	Song, Fuhang,Lin, Rui,Yang, Na,et al. Antibacterial Secondary Metabolites from Marine-Derived Fungus Aspergillus sp. IMCASMF180035[J]. ANTIBIOTICS-BASEL,2021,10(4):9.
APA	Song, Fuhang.,Lin, Rui.,Yang, Na.,Jia, Jia.,Wei, Shangzhu.,...&Xu, Xiuli.(2021).Antibacterial Secondary Metabolites from Marine-Derived Fungus Aspergillus sp. IMCASMF180035.ANTIBIOTICS-BASEL,10(4),9.
MLA	Song, Fuhang,et al."Antibacterial Secondary Metabolites from Marine-Derived Fungus Aspergillus sp. IMCASMF180035".ANTIBIOTICS-BASEL 10.4(2021):9.

条目包含的文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
antibiotics-10-00377（570KB）	期刊论文	出版稿	限制开放	CC BY-NC-SA	浏览